BIOMEA FUSION
Biomea Fusion is a privately held precision medicine company with a mission to revolutionize drug development to create more effective therapies for cancer patients. Biomea Fusion has a development portfolio that targets specific gene alterations which occur in the DNA of patients that translate into key drivers of tumor growth. It is Biomea’s goal to move these potentially breakthrough medicines swiftly through the development process and deliver highly impactful treatments for patients in need. The lead program targets the protein-to-protein interaction between menin and the MLL complex for the treatment of various tumors.
BIOMEA FUSION
Industry:
Biotechnology Life Science Therapeutics
Founded:
2017-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.biomeafusion.com
Total Employee:
11+
Status:
Active
Contact:
(650) 980-9099
Email Addresses:
[email protected]
Total Funding:
56 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Epirium Bio
Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Nuvalent
Nuvalent is a biotechnology company that develops targeted therapies for clinically proven kinase targets in cancer.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Point Sur Investors
Point Sur Investors investment in Series A - Biomea Fusion
Aisling Capital
Aisling Capital investment in Series A - Biomea Fusion
Logos Capital
Logos Capital investment in Series A - Biomea Fusion
Janus Henderson Investors
Janus Henderson Investors investment in Series A - Biomea Fusion
Rock Springs Capital
Rock Springs Capital investment in Series A - Biomea Fusion
Cormorant Asset Management
Cormorant Asset Management investment in Series A - Biomea Fusion
Boxer Capital
Boxer Capital investment in Series A - Biomea Fusion
RTW Investments LLC
RTW Investments LLC investment in Series A - Biomea Fusion
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-01 | Biomea Fusion Announces Appointment of Steve Morris, M.D. as Chief Medical Officer |
Official Site Inspections
http://www.biomeafusion.com Semrush global rank: 1.17 M Semrush visits lastest month: 26.74 K
- Host name: 119.0.153.160.host.secureserver.net
- IP address: 160.153.0.119
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
